Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Fiebo J.W. ten Kate, Cornelis J.F. Van Noorden, Niki A. Ottenhof, Folkert H.M. Morsink, G. Johan A. Offerhaus
Publikováno v:
Cellular Oncology (Dordrecht)
Cellular oncology (Dordrecht), 35(2), 119-126. IOS Press
Cellular oncology (Dordrecht), 35(2), 119-126. IOS Press
Background Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with a 5-year survival rate of
Autor:
Min Wang, Zhipeng Li, Chengyi Sun, Jie Xiao, Jianxin Jiang, Deng Yazhu, Chao Yu, Xingjun Guo, Feng Peng
Publikováno v:
Cellular Oncology (Dordrecht)
Purpose The prognosis of pancreatic cancer ranks among the worst of all cancer types, which is primarily due to the fact that during the past decades little progress has been made in its diagnosis and treatment. Here, we set out to investigate the ro
Autor:
Cathy B. Moelans, Paul J. van Diest, Anya N. A. Milne, Folkert H.M. Morsink, G. Johan A. Offerhaus
Publikováno v:
Cellular Oncology (Dordrecht)
Background The recent ToGA trial results indicated that trastuzumab is a new, effective, and well-tolerated treatment for HER2-positive gastric cancer (GC). Although GC mainly affects older patients, fewer than 10% of GC patients are considered early